AN OVERVIEW. INDIA IS RANKED 15TH IN TERMS OF VALUE IN THE GLOBAL PHARMA MARKET HIGH POPULATIONGROWING ROBUST ECONOMYSLATES INDIA AS A KEY PLAYER ON THE GLOBAL SCENE BENCHMERKS:ACCEPTANCE OF PRODUCT PATENTS IN 2005INDIA HAS THE SECOND HIGHEST FDA MANUFACTURING UNITS, SECOND ONLY TO USA PAV
2. AN OVERVIEW
INDIA IS RANKED 15TH IN TERMS OF VALUE IN THE GLOBAL PHARMA MARKET
GROWING ROBUST ECONOMY
SLATES INDIA AS A KEY PLAYER ON THE GLOBAL SCENE
ACCEPTANCE OF PRODUCT PATENTS IN 2005
INDIA HAS THE SECOND HIGHEST FDA MANUFACTURING UNITS, SECOND ONLY TO USA
PAVES WAY TO INCREASED RESEARCH & INNOVATION
LAUNCH OF NEW PATENTED PRODUCTS
LEADS TO FURTHER GROWTH
3. GROWTH MATRIX
4. PERFORMANCE MATRIX multiply by 4.5 for fig in mil$
7. THE GUIDING STARS
12. MANEESH PHARMACEUTICALS
Certified with SGS UK
14. Maneesh Pharmaceuticals has emerged as a integrated Pharma company with capabilities from Research to Global marketing of Branded Generics and NDDS.
IT is one of the very few companies, which offer specialized facilities dedicated to the same therapeutic group of products.
Anti-infectives (Anti-TB, Anti-malarial, Anti HIV-AIDS)
Oral Contraceptive Pills
Dermatology (Ointments & Creams)
Advancing medicine sustaining healthcare…
15. MANEESH PHAMACEUTICALS
24-24, Kalpataru Court,
Dr. C. G. Marg, Chembur,
Mumbai- 400 074
Tel No. +91-22-2525 2122/23/24
Fax No. +91-22-2525 2121
E-mail: [email protected]
VISIT US AT: www.maneeshpharma.com
16. Success Track World class manufacturing facilities
Exports to over 70 countries
Dedicated units for Anti-TB drugs & Hormones
Expanded domestic market operations
Scouting strategic opportunities off shore
Set up R&D Center /Clinical Research Center
18. A Global Quality CRO
20. Future Strategy:
To expand our operations in USA and Europe
In USA with the Help of Synovics we are on the verge of starting distribution.
We have acquired a company in Europe with existing Registrations and approvals. This will be used as an base to enter European Markets.
We also have plans in progress to acquire a medium sized distributor in UK or Europe.
To expand the Indian operations by adding more products in New Therapeutic segments mainly the chronic segment like diabetes and hypertension. And increasing the reach to cover more doctor populations. (Today we cover approx. 23%). We already have products developed for reaching the same.
To further expand Globally by entering other markets Like Russia, south east Asia and CHINA with own product registrations.
To further expand in Latin America using BRAZIL as a base
To do Backward Integration by manufacturing key API’s required for Own consumption. What next?
21. Standardization of policy, International & domestic
An integrated collective body for governance in the industry
Transparency in operations at all levels
22. India from pharmaceuticals industry view point:
I see India as a hub for deliverance whatever is in demand
I also see India as an already emerged Industry, on the brink of another revolution in the happening,
Not only as manufacturer or a labour offering land but as a global finished goods maker adhering to the quality dynamics
I also see Indian industry further evolving as leader, having a upper hand dealing with lots of synergistic acquisitions.
The largest ever opportunity I see for my industry in my country is for the Brands & Quality Generics both going hand in hand, playing a key role in making drugs available, accessible & affordable
Besides a new generation of emerging speciality & super speciality professionals
And the industry growing further by looking at big boom expected, currently on the verge of sprouting of
23. Our aim is to become a Globally competitive Integrated Pharma solution with capabilities from R & D to Global Marketing. Thank You